Abound Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692 | Hold |
18
| – | – | ﹤0.01% | 832 |
|
|
2025
Q1 | $698 | Sell |
18
-164
| -90% | -$6.36K | ﹤0.01% | 787 |
|
|
2024
Q4 | $6.16K | Buy |
182
+160
| +727% | +$5.41K | ﹤0.01% | 485 |
|
|
2024
Q3 | $900 | Buy |
22
+13
| +144% | +$532 | ﹤0.01% | 792 |
|
|
2024
Q2 | $347 | Sell |
9
-29
| -76% | -$1.12K | ﹤0.01% | 925 |
|
|
2024
Q1 | $1.63K | Sell |
38
-1
| -3% | -$43 | ﹤0.01% | 704 |
|
|
2023
Q4 | $1.44K | Buy |
39
+1
| +3% | +$37 | ﹤0.01% | 704 |
|
|
2023
Q3 | $1.38K | Hold |
38
| – | – | ﹤0.01% | 670 |
|
|
2023
Q2 | $1.36K | Buy |
+38
| New | +$1.36K | ﹤0.01% | 693 |
|